Strata Skin SciencesFRA:E2O 38 Days Inventory is 72.74 as of Dec. 2025, which is 13% below its 10-year median of 83.32. GuruFocus rates FRA:E2O with a GF Score™ of 38/100 and a GF Value™ of €19,176.00. The stock has 4 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Strata Skin Sciences ranks better than 87.31% on this metric.
The historical rank and industry rank for Strata Skin Sciences's Days Inventory or its related term are showing as below:
FRA:E2O'
s Days Inventory Range Over the Past 10 Years
Min: 62.6 Med: 83.32 Max: 131.86
Current: 79.02
During the past 13 years, Strata Skin Sciences's highest Days Inventory was 131.86. The lowest was 62.60. And the median was 83.32.
FRA:E2O's Days Inventory is ranked better than 87.31% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 179.115
vs FRA:E2O: 79.02
Inventory Turnover measures how fast the company turns over its inventory within a year.
Strata Skin Sciences's Inventory Turnover for the
three
months ended in Dec. 2025 was 1.25.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Strata Skin Sciences's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.32.
Strata Skin Sciences (FRA:E2O) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Strata Skin Sciences's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Strata Skin Sciences's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Strata Skin Sciences Days Inventory Related Terms
Strata Skin Sciences Days Inventory Historical Data
* Premium members only.
The historical data trend for Strata Skin Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:E2O vs ODYY, NUMD, PFSA: Days Inventory Comparison
For the Medical Devices subindustry, Strata Skin Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Strata Skin Sciences Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Strata Skin Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Strata Skin Sciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Strata Skin Sciences (FRA:E2O) has a Days Inventory of 72.74 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Strata Skin Sciences and its competitors. This is 13% below median its historical median of 83.32. Over the past decade, Strata Skin Sciences' Days Inventory has ranged from 62.60 to 131.86. According to the industry distribution chart, Strata Skin Sciences ranks #100 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 12.7%.
Is Strata Skin Sciences' Days Inventory too high?
Strata Skin Sciences' current Days Inventory of 72.74 is 13% below median its 10-year median of 83.32. Over the past 10 years, this metric has ranged from a low of 62.60 to a high of 131.86. The Medical Devices & Instruments industry median Days Inventory is 179.12. Strata Skin Sciences' value of 72.74 is 59.4% below this industry median. Based on the distribution chart, Strata Skin Sciences ranks #100 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Strata Skin Sciences has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Strata Skin Sciences' Days Inventory compare to ODYY and NUMD?
According to the Medical Devices & Instruments industry distribution chart, Strata Skin Sciences ranks #100 out of 788 companies for Days Inventory. This places Strata Skin Sciences in the top 13% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.12. Strata Skin Sciences' value of 72.74 is 59.4% below this benchmark. Historically, Strata Skin Sciences' own Days Inventory has ranged from 62.60 to 131.86 over the past decade. While the company's 10-year median is 83.32 vs. the industry median of 179.12, Strata Skin Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.12, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Strata Skin Sciences's current Days Inventory of 72.74 is 59.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Strata Skin Sciences and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Strata Skin Sciences's current Days Inventory is 72.74, which is 13% below median its own 10-year median of 83.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strata Skin Sciences stock overvalued right now?
Strata Skin Sciences (FRA:E2O) has a current Days Inventory of 72.74. The stock's GF Value™ is €19,176.00, compared to a current price of €3.76 — trading 100% below its estimated fair value. The current Days Inventory is 72.74, which is 13% below median its 10-year median of 83.32 and 59.4% below the Medical Devices & Instruments industry median of 179.12. Strata Skin Sciences' overall GF Score™ is 38/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Strata Skin Sciences (FRA:E2O), the current Days Inventory is 72.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Strata Skin Sciences (FRA:E2O) Overvalued in 2026?
Based on GuruFocus' analysis, Strata Skin Sciences stock appears to be undervalued.
The current stock price of €3.76 is trading 100% below its estimated GF Value™ of €19,176.00.
Key valuation signals for FRA:E2O:
Days Inventory: 72.74 (13% below median its 10-year median of 83.32)
GF Value™: €19,176.00 vs. price of €3.76 (100% below fair value)
Industry Position: 59.4% below the Medical Devices & Instruments median (#100 of 788)
No single metric tells the full story. See the FRA:E2O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo, and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver, and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
38GF Score
Get the complete analysis for FRA:E2O
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:E2O has been successfully added to your 
